Variable | Patients with anxiety | Patients without anxiety | Hazard ratio and 95% CI | |||
---|---|---|---|---|---|---|
Cases | Incidence a | Cases | Incidence a | CHR (95 CI%) | AHR (95 CI%) | |
Cancer type | Â | Â | Â | Â | Â | Â |
 Colon cancer | 353 | 0.14 | 1458 | 0.14 | 1.06 (0.94–1.19) | 1.18 (1.05–1.33)* |
 Lung cancer | 324 | 0.13 | 1237 | 0.12 | 1.15 (1.01–1.29)* | 1.24 (1.09–1.40)** |
 Breast cancer | 284 | 0.18 | 1123 | 0.16 | 1.12 (0.98–1.28) | 1.27 (1.11–1.46)** |
 Liver cancer | 336 | 0.14 | 1072 | 0.10 | 1.36 (1.20–1.53)** | 1.19 (1.05–1.35)* |
 Oral cancer | 103 | 0.04 | 475 | 0.04 | 0.92 (0.74–1.13) | 1.07 (0.86–1.34) |
 Prostate cancer | 121 | 0.14 | 294 | 0.08 | 1.77 (1.43–2.19)** | 1.97 (1.59–2.47)** |
 Thyroid cancer | 75 | 0.03 | 165 | 0.02 | 2.02 (1.54–2.66)** | 2.13 (1.60–2.82)** |
 Skin cancer | 89 | 0.04 | 224 | 0.02 | 1.77 (1.38–2.27)** | 2.10 (1.63–2.71)** |
 Stomach cancer | 85 | 0.03 | 411 | 0.04 | 0.91 (0.72–1.15) | 0.96 (0.76–1.22) |
 Gynecological cancer | 148 | 0.09 | 707 | 0.10 | 0.91 (0.76–1.09) | 1.01 (0.85–1.21) |
 Brain cancer | 47 | 0.02 | 130 | 0.01 | 1.55 (1.11–2.17)* | 1.78 (1.26–2.51)* |
 Urological cancer | 150 | 0.06 | 471 | 0.04 | 1.40 (1.16–1.68)** | 1.40 (1.16–1.69)** |
 Leukemia | 41 | 0.02 | 150 | 0.01 | 1.20 (0.85–1.69) | 1.24 (0.87–1.77) |
 Bone cancer | 7 | 0.03+ | 24 | 0.02+ | 1.33 (0.57–3.10) | 1.37 (0.57–3.27) |
 Nose cancer | 74 | 0.03 | 181 | 0.02 | 1.71 (1.31–2.25)** | 1.84 (1.39–2.44)** |